Clearance Summary
illumigene Pertussis DNA Amplification Assay received FDA 510(k) clearance under submission number K152285, sponsored by Meridian Bioscience, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Microbiology review panel. The statutory decision date of record is 2015-11-10.
- Submission: K152285
- Applicant / Sponsor: Meridian Bioscience, Inc.
- Clearance pathway: Traditional
- Review panel: Microbiology
- Device class: Class II
- Regulation citation: 21 CFR 866.3980
- Decision date: 2015-11-10
Classification & Regulation
This clearance is catalogued under FDA product code OZZ and 21 CFR 866.3980, within the Microbiology review panel as a Class II device.